arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CVS HEALTH Corp

CVS
$81.01 ▲ +1.05 (+1.31%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Bullish
auto_awesome

Analytical Summary

CVS HEALTH Corp shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $103.6B
Dividend Yield 0.82%
Revenue Growth 7.3% ↗
Op. Margin 4.4% ↘
ROIC 4.4% ↘
FCF / Share $4.42 ↗
Trailing P/E 34.8x
Price / Book 1.3x
FCF Yield 5.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$106.10B
↑ +7.3% —
Net Income Profit after all expenses
$2.98B
↑ +191.8% —
Operating Margin Operating profit as % of sales
4.4%
↓ -4.9% 31th
FCF / Share Free cash flow per share
$4.42
↑ +65.5% —
Long-Term Debt Long-term obligations
$63.48B
↓ -3.4% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
32
Returns ↓
48
Financial Health ↓
77
Cash Quality ↑
95

Dividend History

Dividend / share · sourced from SEC filings
$2.66 Latest / share
+0.0% YoY
+8.4% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 75 quarters